EP Patent

EP2266562A1 — Use of derivatives of indoles for the treatment of cancer

Assigned to Centre National de la Recherche Scientifique CNRS · Expires 2010-12-29 · 15y expired

What this patent protects

The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.

USPTO Abstract

The present invention relates to the use of derivatives of indoles having a general formula (I) as follow: for the manufacture of a pharmaceutical composition intended for the treatment of cancer.

Drugs covered by this patent

Patent Metadata

Patent number
EP2266562A1
Jurisdiction
EP
Classification
—
Expires
2010-12-29
Drug substance claim
No
Drug product claim
No
Assignee
Centre National de la Recherche Scientifique CNRS
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.